These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16182282

  • 1. Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig.
    Kruuse C, Khurana TS, Rybalkin SD, Birk S, Engel U, Edvinsson L, Olesen J.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):105-14. PubMed ID: 16182282
    [Abstract] [Full Text] [Related]

  • 2. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
    Kruuse C, Rybalkin SD, Khurana TS, Jansen-Olesen I, Olesen J, Edvinsson L.
    Eur J Pharmacol; 2001 May 18; 420(1):55-65. PubMed ID: 11412839
    [Abstract] [Full Text] [Related]

  • 3. Relaxant effect of sildenafil in the rabbit basilar artery.
    Salom JB, Burguete MC, Pérez-Asensio FJ, Castelló-Ruiz M, Torregrosa G, Alborch E.
    Vascul Pharmacol; 2006 Jan 18; 44(1):10-6. PubMed ID: 16325476
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
    Klein T, Eltze M, Grebe T, Hatzelmann A, Kömhoff M.
    Cardiovasc Res; 2007 Jul 15; 75(2):390-7. PubMed ID: 17383621
    [Abstract] [Full Text] [Related]

  • 5. Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.
    Pauvert O, Lugnier C, Keravis T, Marthan R, Rousseau E, Savineau JP.
    Br J Pharmacol; 2003 Jun 15; 139(3):513-22. PubMed ID: 12788811
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vasorelaxing effect of BAY 41-2272 in rat basilar artery: involvement of cGMP-dependent and independent mechanisms.
    Teixeira CE, Priviero FB, Todd J, Webb RC.
    Hypertension; 2006 Mar 15; 47(3):596-602. PubMed ID: 16391173
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5).
    Kotera J, Fujishige K, Michibata H, Yuasa K, Kubo A, Nakamura Y, Omori K.
    Biochem Pharmacol; 2000 Nov 01; 60(9):1333-41. PubMed ID: 11008127
    [Abstract] [Full Text] [Related]

  • 16. In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.
    Gratzke C, Uckert S, Kedia G, Reich O, Schlenker B, Seitz M, Becker AJ, Stief CG.
    Urol Res; 2007 Feb 01; 35(1):49-54. PubMed ID: 17102958
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
    Turko IV, Ballard SA, Francis SH, Corbin JD.
    Mol Pharmacol; 1999 Jul 01; 56(1):124-30. PubMed ID: 10385692
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.